Celldex Therapeutics
CLDX
#5014
Rank
A$2.10 B
Marketcap
$31.67
Share price
0.80%
Change (1 day)
-49.30%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -$3.60

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.79. In 2022 the company made an earnings per share (EPS) of -$3.77 a decrease over its 2021 EPS that were of -$2.59.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.60-4.55%
2022-$3.7745.73%
2021-$2.59-23.36%
2020-$3.38-41.05%
2019-$5.73-76.95%
2018-$24.8845.03%
2017-$17.15-42.54%
2016-$29.85-3.82%
2015-$31.04-0.76%
2014-$31.2729.41%
2013-$24.170%
2012-$24.17-9.73%
2011-$26.771312.5%
2010-$1.90-95.79%
2009-$44.98-49.64%
2008-$89.32-82.64%
2007-$514.58-44.98%
2006-$935.341270.83%
2005-$68.2333.33%
2004-$51.17-10%
2003-$56.86-16.67%
2002-$68.23-38.46%
2001-$110.88-4.88%
2000-$116.56-81.66%
1999-$635.41-87.2%
1998-$4,962206.39%
1997-$1,62013.02%
1996-$1,433

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$6.33 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.34-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-$19.08 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.35-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.94-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.53-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-$0.90-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA